Physician profile
Mark H Chen
NPI 1205022274
$2,596.66
in general payments reported to CMS, 2019-2025
15 companies · $907 in 2025
The $907 reported for 2025 was more than what 97% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $546 · 2024: $1,143 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,528 · Entertainment: $68.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,528.28 |
| Entertainment | $68.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $500.62 | 2023-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $334.67 | 2025 | Vyrsa V1, Senza |
| Spinal Simplicity, LLC | $327.99 | 2024-2025 | Ha Minuteman G3-R |
| Sonex Health, INC. | $270.84 | 2025 | Sx-One Microknife |
| Foundation Fusion Solutions, LLC | $230.72 | 2024 | |
| Abbott Laboratories | $220.98 | 2024 | Proclaim |
| Nevro Corp. | $194.79 | 2023 | Senza |
| Vertos Medical, INC. | $169.10 | 2023-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $122.24 | 2024 | Evoke |
| Averitas Pharma INC. | $76.50 | 2024 | Qutenza |
| Si-Bone, INC. | $56.58 | 2024 | |
| Abbvie INC. | $30.12 | 2024 | |
| Boston Scientific Corporation | $23.27 | 2024 | Intracept |
| Nalu Medical, INC. | $21.65 | 2023 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $16.59 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.